| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 91 | 2024 | 4668 | 5.220 |
Why?
|
| Fontan Procedure | 20 | 2018 | 791 | 2.160 |
Why?
|
| Heart Septal Defects, Atrial | 13 | 2009 | 461 | 1.600 |
Why?
|
| Pregnancy Complications, Cardiovascular | 14 | 2021 | 516 | 1.480 |
Why?
|
| Eisenmenger Complex | 10 | 2019 | 26 | 1.280 |
Why?
|
| Hypertension, Pulmonary | 19 | 2019 | 1570 | 1.190 |
Why?
|
| Pulmonary Artery | 15 | 2019 | 1919 | 1.070 |
Why?
|
| Cardiology | 15 | 2019 | 1723 | 1.050 |
Why?
|
| Foramen Ovale, Patent | 6 | 2014 | 214 | 1.020 |
Why?
|
| Tetralogy of Fallot | 16 | 2018 | 631 | 0.930 |
Why?
|
| Heart Ventricles | 14 | 2018 | 3811 | 0.900 |
Why?
|
| Tricuspid Valve Insufficiency | 4 | 2018 | 355 | 0.880 |
Why?
|
| Transposition of Great Vessels | 8 | 2015 | 590 | 0.840 |
Why?
|
| Biological Specimen Banks | 2 | 2018 | 776 | 0.790 |
Why?
|
| Cardiac Surgical Procedures | 17 | 2016 | 3618 | 0.760 |
Why?
|
| Heart Valve Diseases | 8 | 2020 | 1047 | 0.710 |
Why?
|
| Heart Septal Defects, Ventricular | 6 | 2012 | 491 | 0.710 |
Why?
|
| Aortic Coarctation | 6 | 2016 | 282 | 0.690 |
Why?
|
| Tricuspid Valve | 3 | 2018 | 409 | 0.610 |
Why?
|
| Septal Occluder Device | 3 | 2014 | 126 | 0.590 |
Why?
|
| Exercise Tolerance | 11 | 2019 | 826 | 0.590 |
Why?
|
| Angioplasty, Balloon | 5 | 2012 | 597 | 0.550 |
Why?
|
| Continuity of Patient Care | 3 | 2013 | 1067 | 0.530 |
Why?
|
| Heart Septal Defects | 3 | 2011 | 191 | 0.500 |
Why?
|
| Hemodynamics | 16 | 2019 | 4169 | 0.500 |
Why?
|
| Heart Failure | 12 | 2024 | 11835 | 0.490 |
Why?
|
| Exercise Test | 14 | 2019 | 2125 | 0.480 |
Why?
|
| Arterio-Arterial Fistula | 2 | 2014 | 20 | 0.480 |
Why?
|
| Adult | 128 | 2024 | 219847 | 0.470 |
Why?
|
| Galectin 3 | 1 | 2016 | 240 | 0.460 |
Why?
|
| Iloprost | 1 | 2013 | 25 | 0.440 |
Why?
|
| Bioprosthesis | 2 | 2014 | 599 | 0.420 |
Why?
|
| Prosthesis Implantation | 4 | 2014 | 593 | 0.420 |
Why?
|
| Aortic Valve | 4 | 2013 | 1996 | 0.410 |
Why?
|
| Prostheses and Implants | 8 | 2012 | 1272 | 0.400 |
Why?
|
| Antihypertensive Agents | 6 | 2019 | 2063 | 0.400 |
Why?
|
| Arrhythmias, Cardiac | 8 | 2020 | 2255 | 0.390 |
Why?
|
| Specimen Handling | 1 | 2016 | 708 | 0.390 |
Why?
|
| Heart Diseases | 8 | 2021 | 2809 | 0.390 |
Why?
|
| Pediatrics | 4 | 2019 | 3587 | 0.380 |
Why?
|
| Vasodilator Agents | 3 | 2013 | 977 | 0.380 |
Why?
|
| Humans | 194 | 2024 | 760261 | 0.370 |
Why?
|
| Coronary Vessel Anomalies | 5 | 2017 | 316 | 0.370 |
Why?
|
| Aortic Valve Insufficiency | 4 | 2015 | 584 | 0.360 |
Why?
|
| Embolism, Paradoxical | 3 | 2012 | 55 | 0.360 |
Why?
|
| Adolescent | 63 | 2019 | 87747 | 0.350 |
Why?
|
| Young Adult | 48 | 2024 | 58673 | 0.340 |
Why?
|
| Sulfonamides | 5 | 2019 | 1973 | 0.340 |
Why?
|
| Heart Valve Prosthesis | 4 | 2015 | 1494 | 0.330 |
Why?
|
| Equipment Design | 3 | 2014 | 3520 | 0.320 |
Why?
|
| Heart Atria | 4 | 2012 | 1344 | 0.320 |
Why?
|
| Exercise | 6 | 2017 | 5783 | 0.320 |
Why?
|
| Dental Implantation, Endosseous | 1 | 2013 | 528 | 0.310 |
Why?
|
| Vascular Resistance | 7 | 2013 | 932 | 0.310 |
Why?
|
| Pulmonary Circulation | 7 | 2016 | 743 | 0.310 |
Why?
|
| Aorta | 2 | 2013 | 2042 | 0.310 |
Why?
|
| Aortic Aneurysm | 1 | 2013 | 646 | 0.310 |
Why?
|
| Echocardiography, Doppler | 5 | 2017 | 900 | 0.310 |
Why?
|
| Ischemic Attack, Transient | 5 | 2014 | 899 | 0.310 |
Why?
|
| Pregnancy Outcome | 7 | 2021 | 2906 | 0.310 |
Why?
|
| Female | 122 | 2024 | 391011 | 0.310 |
Why?
|
| Follow-Up Studies | 35 | 2018 | 39254 | 0.300 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2010 | 220 | 0.300 |
Why?
|
| Pulmonary Embolism | 5 | 2012 | 2544 | 0.300 |
Why?
|
| Liver Cirrhosis | 5 | 2016 | 1925 | 0.290 |
Why?
|
| Male | 107 | 2024 | 359413 | 0.280 |
Why?
|
| Postoperative Complications | 15 | 2020 | 15680 | 0.280 |
Why?
|
| Echocardiography | 8 | 2017 | 4980 | 0.280 |
Why?
|
| Coronary Thrombosis | 1 | 2010 | 486 | 0.280 |
Why?
|
| Ventricular Dysfunction, Right | 5 | 2013 | 615 | 0.280 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 3822 | 0.270 |
Why?
|
| Pulmonary Valve | 3 | 2018 | 414 | 0.270 |
Why?
|
| Ventricular Septal Rupture | 2 | 2013 | 17 | 0.260 |
Why?
|
| Middle Aged | 77 | 2024 | 220175 | 0.260 |
Why?
|
| Thromboembolism | 3 | 2013 | 1016 | 0.260 |
Why?
|
| Treatment Outcome | 39 | 2020 | 64947 | 0.260 |
Why?
|
| Disease Management | 7 | 2019 | 2508 | 0.260 |
Why?
|
| Efficiency, Organizational | 1 | 2010 | 697 | 0.250 |
Why?
|
| Long-Term Care | 2 | 2011 | 628 | 0.250 |
Why?
|
| Boston | 10 | 2018 | 9282 | 0.250 |
Why?
|
| Thrombolytic Therapy | 1 | 2014 | 2108 | 0.240 |
Why?
|
| Oxygen Consumption | 8 | 2018 | 1840 | 0.240 |
Why?
|
| American Heart Association | 8 | 2021 | 1081 | 0.240 |
Why?
|
| Fibrinolytic Agents | 1 | 2014 | 2167 | 0.230 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2019 | 3967 | 0.230 |
Why?
|
| Risk Factors | 35 | 2023 | 74269 | 0.230 |
Why?
|
| Pulmonary Atresia | 6 | 2012 | 159 | 0.230 |
Why?
|
| Aortic Valve Stenosis | 3 | 2013 | 2064 | 0.220 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2017 | 269 | 0.220 |
Why?
|
| Patient Transfer | 1 | 2010 | 778 | 0.210 |
Why?
|
| Epoprostenol | 2 | 2003 | 248 | 0.210 |
Why?
|
| Retrospective Studies | 39 | 2020 | 80301 | 0.210 |
Why?
|
| Age Factors | 14 | 2019 | 18415 | 0.210 |
Why?
|
| Classification | 2 | 2020 | 127 | 0.200 |
Why?
|
| Myocardial Perfusion Imaging | 2 | 2019 | 572 | 0.200 |
Why?
|
| Stroke | 8 | 2014 | 9945 | 0.200 |
Why?
|
| Catheterization | 4 | 2011 | 1432 | 0.190 |
Why?
|
| Ventricular Function, Right | 2 | 2017 | 610 | 0.190 |
Why?
|
| Palliative Care | 4 | 2024 | 3607 | 0.180 |
Why?
|
| Evidence-Based Medicine | 4 | 2019 | 3696 | 0.180 |
Why?
|
| Registries | 7 | 2018 | 8449 | 0.180 |
Why?
|
| Patient Education as Topic | 4 | 2019 | 2311 | 0.180 |
Why?
|
| Death, Sudden, Cardiac | 6 | 2013 | 1572 | 0.180 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2020 | 63 | 0.180 |
Why?
|
| Risk Assessment | 17 | 2016 | 24086 | 0.180 |
Why?
|
| Prospective Studies | 20 | 2023 | 54263 | 0.170 |
Why?
|
| Coronary Angiography | 7 | 2016 | 4560 | 0.170 |
Why?
|
| Venous Insufficiency | 2 | 2011 | 111 | 0.170 |
Why?
|
| Heart Transplantation | 4 | 2018 | 3217 | 0.170 |
Why?
|
| Delivery, Obstetric | 3 | 2019 | 933 | 0.170 |
Why?
|
| Patient Care Planning | 1 | 2004 | 909 | 0.160 |
Why?
|
| Child | 29 | 2019 | 79758 | 0.160 |
Why?
|
| Platelet Aggregation Inhibitors | 4 | 2012 | 3201 | 0.160 |
Why?
|
| Cohort Studies | 20 | 2022 | 41317 | 0.160 |
Why?
|
| Coronary Vessels | 1 | 2010 | 3112 | 0.160 |
Why?
|
| Sinus of Valsalva | 2 | 2016 | 60 | 0.150 |
Why?
|
| Reoperation | 5 | 2020 | 4292 | 0.150 |
Why?
|
| Breathing Exercises | 1 | 2018 | 60 | 0.150 |
Why?
|
| Inhalation | 1 | 2018 | 143 | 0.150 |
Why?
|
| Respiratory Muscles | 1 | 2018 | 142 | 0.150 |
Why?
|
| Physicians | 2 | 2013 | 4590 | 0.150 |
Why?
|
| Prognosis | 15 | 2022 | 29636 | 0.150 |
Why?
|
| Erythrocyte Indices | 1 | 2018 | 145 | 0.150 |
Why?
|
| Standard of Care | 2 | 2019 | 552 | 0.150 |
Why?
|
| Aorta, Thoracic | 3 | 2013 | 1097 | 0.150 |
Why?
|
| Pulmonary Valve Stenosis | 3 | 2007 | 172 | 0.150 |
Why?
|
| Caregivers | 1 | 2009 | 2222 | 0.140 |
Why?
|
| Dilatation, Pathologic | 3 | 2013 | 527 | 0.140 |
Why?
|
| Cardiac Output, Low | 2 | 2012 | 192 | 0.140 |
Why?
|
| Child, Preschool | 20 | 2019 | 42034 | 0.140 |
Why?
|
| Albuminuria | 2 | 2018 | 659 | 0.140 |
Why?
|
| Pregnancy | 16 | 2021 | 29725 | 0.140 |
Why?
|
| Ventricular Remodeling | 3 | 2013 | 1259 | 0.140 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2017 | 87 | 0.140 |
Why?
|
| Prevalence | 12 | 2024 | 15687 | 0.140 |
Why?
|
| Ventricular Pressure | 1 | 2017 | 204 | 0.140 |
Why?
|
| United States | 28 | 2023 | 72363 | 0.140 |
Why?
|
| Dyspnea | 3 | 2012 | 1352 | 0.130 |
Why?
|
| Echocardiography, Stress | 1 | 2017 | 134 | 0.130 |
Why?
|
| Time Factors | 15 | 2019 | 40133 | 0.130 |
Why?
|
| Hospitals, Pediatric | 4 | 2013 | 1853 | 0.130 |
Why?
|
| Consensus | 3 | 2020 | 3106 | 0.130 |
Why?
|
| Myocardial Infarction | 5 | 2013 | 11891 | 0.130 |
Why?
|
| Referral and Consultation | 3 | 2014 | 3598 | 0.130 |
Why?
|
| Intracranial Embolism | 2 | 2010 | 192 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 3 | 2013 | 1469 | 0.130 |
Why?
|
| Posture | 2 | 2017 | 954 | 0.130 |
Why?
|
| Cross-Sectional Studies | 17 | 2019 | 25928 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2014 | 10340 | 0.130 |
Why?
|
| Cystatin C | 1 | 2016 | 270 | 0.120 |
Why?
|
| Infant | 16 | 2020 | 36030 | 0.120 |
Why?
|
| Cheyne-Stokes Respiration | 1 | 2014 | 38 | 0.120 |
Why?
|
| Myocardial Ischemia | 2 | 2016 | 2161 | 0.120 |
Why?
|
| Scimitar Syndrome | 1 | 2014 | 31 | 0.120 |
Why?
|
| Cyanosis | 1 | 2015 | 86 | 0.120 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2015 | 51 | 0.120 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2017 | 265 | 0.120 |
Why?
|
| Medicine | 1 | 2023 | 943 | 0.120 |
Why?
|
| Cause of Death | 4 | 2017 | 3723 | 0.120 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2019 | 1067 | 0.120 |
Why?
|
| Infant, Newborn | 12 | 2020 | 26168 | 0.120 |
Why?
|
| Heart Valve Prosthesis Implantation | 5 | 2013 | 1583 | 0.120 |
Why?
|
| Anastomosis, Surgical | 2 | 2015 | 983 | 0.120 |
Why?
|
| Administration, Inhalation | 5 | 2013 | 1156 | 0.120 |
Why?
|
| Pacemaker, Artificial | 3 | 2010 | 815 | 0.110 |
Why?
|
| Cesarean Section | 3 | 2019 | 1386 | 0.110 |
Why?
|
| Survival Analysis | 8 | 2018 | 10185 | 0.110 |
Why?
|
| Data Collection | 2 | 2013 | 3317 | 0.110 |
Why?
|
| Aged | 31 | 2023 | 168995 | 0.110 |
Why?
|
| Tricuspid Atresia | 1 | 2013 | 37 | 0.110 |
Why?
|
| Waiting Lists | 1 | 2018 | 754 | 0.110 |
Why?
|
| Spirometry | 2 | 2014 | 924 | 0.110 |
Why?
|
| Clinical Protocols | 1 | 2019 | 1439 | 0.110 |
Why?
|
| Cardiac Care Facilities | 1 | 2013 | 34 | 0.110 |
Why?
|
| Paraganglioma | 1 | 2015 | 142 | 0.110 |
Why?
|
| Health Policy | 3 | 2014 | 2678 | 0.110 |
Why?
|
| Pulmonary Wedge Pressure | 3 | 2012 | 273 | 0.110 |
Why?
|
| Vena Cava, Superior | 2 | 2011 | 197 | 0.110 |
Why?
|
| Galectins | 1 | 2016 | 282 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 5 | 2016 | 7468 | 0.110 |
Why?
|
| Delivery of Health Care | 5 | 2023 | 5324 | 0.110 |
Why?
|
| Hyaluronic Acid | 1 | 2016 | 482 | 0.110 |
Why?
|
| Canada | 4 | 2013 | 2128 | 0.100 |
Why?
|
| Electronic Health Records | 1 | 2010 | 4763 | 0.100 |
Why?
|
| Warfarin | 3 | 2013 | 1516 | 0.100 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2011 | 218 | 0.100 |
Why?
|
| Pheochromocytoma | 1 | 2015 | 328 | 0.100 |
Why?
|
| Electrocardiography | 6 | 2016 | 6413 | 0.100 |
Why?
|
| Double-Blind Method | 6 | 2019 | 12412 | 0.100 |
Why?
|
| Stents | 5 | 2010 | 3303 | 0.100 |
Why?
|
| Tachycardia, Ventricular | 5 | 2013 | 1302 | 0.100 |
Why?
|
| Endocarditis, Bacterial | 2 | 2013 | 445 | 0.100 |
Why?
|
| Patient Care Management | 1 | 2015 | 303 | 0.100 |
Why?
|
| Liver | 4 | 2016 | 7512 | 0.100 |
Why?
|
| Organ Transplantation | 1 | 2022 | 1150 | 0.100 |
Why?
|
| Ebstein Anomaly | 1 | 2012 | 101 | 0.100 |
Why?
|
| Linear Models | 4 | 2015 | 5876 | 0.100 |
Why?
|
| Anesthesia, Obstetrical | 2 | 2011 | 233 | 0.100 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2012 | 192 | 0.100 |
Why?
|
| Survival Rate | 7 | 2020 | 12806 | 0.100 |
Why?
|
| Maxillary Sinus | 1 | 2013 | 180 | 0.090 |
Why?
|
| Multiple Organ Failure | 1 | 2014 | 387 | 0.090 |
Why?
|
| Risk Adjustment | 1 | 2015 | 601 | 0.090 |
Why?
|
| Brain Abscess | 1 | 2011 | 120 | 0.090 |
Why?
|
| Respiration Disorders | 1 | 2014 | 368 | 0.090 |
Why?
|
| Radiation Dosage | 1 | 2019 | 1957 | 0.090 |
Why?
|
| Hospital Charges | 1 | 2013 | 359 | 0.090 |
Why?
|
| Vascular Fistula | 1 | 2011 | 50 | 0.090 |
Why?
|
| Pulmonary Edema | 2 | 2006 | 409 | 0.090 |
Why?
|
| Propensity Score | 1 | 2018 | 1918 | 0.090 |
Why?
|
| Blood Proteins | 1 | 2016 | 1172 | 0.090 |
Why?
|
| Diastole | 1 | 2013 | 788 | 0.090 |
Why?
|
| Lung Abscess | 1 | 2010 | 41 | 0.090 |
Why?
|
| Defibrillators, Implantable | 3 | 2008 | 1499 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2001 | 2510 | 0.080 |
Why?
|
| Pregnancy, High-Risk | 1 | 2010 | 119 | 0.080 |
Why?
|
| Alveolar Bone Loss | 1 | 2013 | 390 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2012 | 1430 | 0.080 |
Why?
|
| Hyperaldosteronism | 1 | 2012 | 244 | 0.080 |
Why?
|
| Organizational Case Studies | 1 | 2010 | 301 | 0.080 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2015 | 734 | 0.080 |
Why?
|
| Down Syndrome | 2 | 2019 | 891 | 0.080 |
Why?
|
| Aspirin | 3 | 2013 | 3365 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2019 | 2689 | 0.080 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2013 | 1038 | 0.080 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2014 | 389 | 0.080 |
Why?
|
| Hospitals, Special | 1 | 2009 | 90 | 0.080 |
Why?
|
| Angioplasty | 1 | 2011 | 360 | 0.080 |
Why?
|
| Parents | 2 | 2014 | 3547 | 0.080 |
Why?
|
| Biomedical Research | 4 | 2013 | 3421 | 0.080 |
Why?
|
| End Stage Liver Disease | 1 | 2013 | 347 | 0.080 |
Why?
|
| Migraine Disorders | 3 | 2013 | 1693 | 0.080 |
Why?
|
| Switzerland | 1 | 2009 | 323 | 0.080 |
Why?
|
| Ontario | 1 | 2009 | 405 | 0.080 |
Why?
|
| Nitric Oxide | 5 | 2001 | 2141 | 0.080 |
Why?
|
| Pilot Projects | 5 | 2018 | 8553 | 0.080 |
Why?
|
| Severity of Illness Index | 7 | 2018 | 15827 | 0.080 |
Why?
|
| Anticoagulants | 4 | 2015 | 4896 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 1 | 2016 | 2178 | 0.080 |
Why?
|
| Collateral Circulation | 2 | 2007 | 292 | 0.080 |
Why?
|
| Prosthesis-Related Infections | 1 | 2013 | 486 | 0.070 |
Why?
|
| Aldosterone | 1 | 2012 | 868 | 0.070 |
Why?
|
| Parturition | 1 | 2011 | 445 | 0.070 |
Why?
|
| Reference Values | 1 | 2015 | 4920 | 0.070 |
Why?
|
| Documentation | 1 | 2014 | 892 | 0.070 |
Why?
|
| Prosthesis Design | 2 | 2013 | 2127 | 0.070 |
Why?
|
| Drainage | 2 | 2010 | 1161 | 0.070 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 1215 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2012 | 853 | 0.070 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2007 | 119 | 0.070 |
Why?
|
| Constriction, Pathologic | 1 | 2011 | 1098 | 0.070 |
Why?
|
| Patients | 1 | 2014 | 906 | 0.070 |
Why?
|
| Italy | 1 | 2009 | 840 | 0.070 |
Why?
|
| Streptococcal Infections | 1 | 2011 | 617 | 0.070 |
Why?
|
| Sex Factors | 4 | 2016 | 10530 | 0.070 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 2061 | 0.070 |
Why?
|
| Hemoglobinopathies | 1 | 2007 | 96 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 2012 | 736 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2016 | 4127 | 0.070 |
Why?
|
| Radiology, Interventional | 1 | 2011 | 475 | 0.070 |
Why?
|
| Specialization | 2 | 2022 | 779 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2019 | 3011 | 0.070 |
Why?
|
| Publishing | 1 | 2014 | 837 | 0.070 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2014 | 1880 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 2013 | 1534 | 0.070 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2015 | 1419 | 0.070 |
Why?
|
| Tachycardia | 1 | 2008 | 603 | 0.070 |
Why?
|
| Prenatal Care | 3 | 2021 | 1128 | 0.070 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2012 | 693 | 0.070 |
Why?
|
| Oximetry | 1 | 2009 | 461 | 0.070 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2024 | 4547 | 0.070 |
Why?
|
| Secondary Prevention | 3 | 2012 | 1548 | 0.060 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 2 | 2010 | 149 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2016 | 6545 | 0.060 |
Why?
|
| Predictive Value of Tests | 7 | 2017 | 15273 | 0.060 |
Why?
|
| Societies, Medical | 2 | 2015 | 3903 | 0.060 |
Why?
|
| Chronic Disease | 3 | 2014 | 9283 | 0.060 |
Why?
|
| Career Choice | 1 | 2012 | 755 | 0.060 |
Why?
|
| Therapies, Investigational | 1 | 2006 | 111 | 0.060 |
Why?
|
| Aged, 80 and over | 8 | 2019 | 58947 | 0.060 |
Why?
|
| Advance Care Planning | 1 | 2013 | 697 | 0.060 |
Why?
|
| Health Resources | 1 | 2011 | 936 | 0.060 |
Why?
|
| Cardiovascular System | 1 | 2012 | 850 | 0.060 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2011 | 517 | 0.060 |
Why?
|
| Heparin Antagonists | 1 | 2004 | 33 | 0.060 |
Why?
|
| Liver Function Tests | 2 | 2016 | 524 | 0.060 |
Why?
|
| Survivors | 3 | 2013 | 2367 | 0.060 |
Why?
|
| Fetal Heart | 1 | 2006 | 281 | 0.060 |
Why?
|
| Health Status | 2 | 2018 | 4081 | 0.060 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2014 | 404 | 0.060 |
Why?
|
| Coronary Artery Disease | 2 | 2021 | 6661 | 0.060 |
Why?
|
| Multivariate Analysis | 6 | 2014 | 12156 | 0.060 |
Why?
|
| Protamines | 1 | 2004 | 111 | 0.060 |
Why?
|
| Netherlands | 1 | 2009 | 2213 | 0.060 |
Why?
|
| Decompression Sickness | 1 | 2004 | 16 | 0.060 |
Why?
|
| Dental Implants | 1 | 2013 | 791 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 1935 | 0.060 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 1416 | 0.060 |
Why?
|
| Patient Admission | 1 | 2011 | 1384 | 0.060 |
Why?
|
| Patient Participation | 1 | 2013 | 1437 | 0.060 |
Why?
|
| Hospitalization | 4 | 2021 | 10761 | 0.060 |
Why?
|
| Connective Tissue Diseases | 2 | 2019 | 286 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 2178 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2016 | 22041 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2011 | 1196 | 0.050 |
Why?
|
| Motor Activity | 1 | 2013 | 2687 | 0.050 |
Why?
|
| Ultrasonography | 5 | 2013 | 5960 | 0.050 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2012 | 1108 | 0.050 |
Why?
|
| Balloon Occlusion | 1 | 2004 | 127 | 0.050 |
Why?
|
| Postnatal Care | 2 | 2019 | 260 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2008 | 1723 | 0.050 |
Why?
|
| Positron-Emission Tomography | 2 | 2019 | 6457 | 0.050 |
Why?
|
| Troponin | 1 | 2006 | 516 | 0.050 |
Why?
|
| Forecasting | 2 | 2014 | 2931 | 0.050 |
Why?
|
| Proportional Hazards Models | 6 | 2016 | 12532 | 0.050 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2006 | 294 | 0.050 |
Why?
|
| Observer Variation | 3 | 2020 | 2596 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 1415 | 0.050 |
Why?
|
| Patient Selection | 2 | 2018 | 4276 | 0.050 |
Why?
|
| Aneurysm, False | 1 | 2005 | 257 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 3335 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2004 | 590 | 0.050 |
Why?
|
| Heart Function Tests | 1 | 2003 | 319 | 0.050 |
Why?
|
| Thrombectomy | 1 | 2007 | 707 | 0.050 |
Why?
|
| Europe | 3 | 2014 | 3433 | 0.050 |
Why?
|
| Cardiac Volume | 2 | 2013 | 199 | 0.050 |
Why?
|
| Length of Stay | 3 | 2013 | 6472 | 0.050 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2010 | 1745 | 0.050 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 848 | 0.050 |
Why?
|
| Running | 1 | 2006 | 483 | 0.050 |
Why?
|
| Cerebrovascular Disorders | 1 | 2009 | 1500 | 0.050 |
Why?
|
| Embolization, Therapeutic | 2 | 2007 | 1411 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 2129 | 0.050 |
Why?
|
| Blood Circulation | 2 | 2013 | 249 | 0.050 |
Why?
|
| Electrodes, Implanted | 1 | 2006 | 833 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 3451 | 0.050 |
Why?
|
| Coronary Circulation | 2 | 2016 | 1578 | 0.050 |
Why?
|
| Thoracic Surgery | 1 | 2008 | 722 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2016 | 3327 | 0.050 |
Why?
|
| Atherectomy, Coronary | 1 | 2001 | 146 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2012 | 8551 | 0.050 |
Why?
|
| Kidney | 1 | 2016 | 7072 | 0.050 |
Why?
|
| Regional Medical Programs | 1 | 2001 | 68 | 0.050 |
Why?
|
| Abortion, Spontaneous | 1 | 2006 | 530 | 0.050 |
Why?
|
| Terminal Care | 1 | 2013 | 1759 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3870 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 2003 | 2235 | 0.040 |
Why?
|
| Congresses as Topic | 2 | 2016 | 804 | 0.040 |
Why?
|
| Extraction, Obstetrical | 1 | 2019 | 28 | 0.040 |
Why?
|
| Incidence | 7 | 2013 | 21378 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 3242 | 0.040 |
Why?
|
| Valsalva Maneuver | 1 | 2019 | 98 | 0.040 |
Why?
|
| Health Services Accessibility | 2 | 2014 | 5396 | 0.040 |
Why?
|
| Creatinine | 2 | 2016 | 1906 | 0.040 |
Why?
|
| Gadolinium DTPA | 1 | 2002 | 826 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2007 | 4900 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2014 | 4361 | 0.040 |
Why?
|
| Inspiratory Capacity | 1 | 2018 | 35 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2004 | 1735 | 0.040 |
Why?
|
| Acetylcholine | 3 | 1996 | 629 | 0.040 |
Why?
|
| ROC Curve | 2 | 2017 | 3568 | 0.040 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2001 | 504 | 0.040 |
Why?
|
| Disease Progression | 3 | 2013 | 13505 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2019 | 2982 | 0.040 |
Why?
|
| Diuretics | 1 | 2001 | 612 | 0.040 |
Why?
|
| Gestational Age | 1 | 2006 | 3564 | 0.040 |
Why?
|
| Hexosaminidases | 1 | 2016 | 45 | 0.040 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 20048 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2010 | 3257 | 0.030 |
Why?
|
| Pulmonary Ventilation | 1 | 2018 | 371 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2012 | 8018 | 0.030 |
Why?
|
| Endocardial Cushion Defects | 1 | 1996 | 43 | 0.030 |
Why?
|
| Sarcoidosis | 1 | 2001 | 520 | 0.030 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 15740 | 0.030 |
Why?
|
| Postpartum Hemorrhage | 1 | 2019 | 265 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 12968 | 0.030 |
Why?
|
| Heart-Lung Transplantation | 1 | 1995 | 87 | 0.030 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2016 | 323 | 0.030 |
Why?
|
| Self Report | 2 | 2018 | 3707 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2017 | 327 | 0.030 |
Why?
|
| Urinalysis | 1 | 2016 | 368 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2024 | 1940 | 0.030 |
Why?
|
| Electric Countershock | 2 | 2008 | 537 | 0.030 |
Why?
|
| Social Support | 1 | 2024 | 2145 | 0.030 |
Why?
|
| Comorbidity | 3 | 2013 | 10552 | 0.030 |
Why?
|
| Cardiac Output | 1 | 2016 | 837 | 0.030 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2015 | 143 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2004 | 3483 | 0.030 |
Why?
|
| Thrombosis | 1 | 2007 | 3052 | 0.030 |
Why?
|
| Brachytherapy | 1 | 2001 | 1240 | 0.030 |
Why?
|
| Biopsy | 2 | 2016 | 6775 | 0.030 |
Why?
|
| Smoking | 1 | 2010 | 9070 | 0.030 |
Why?
|
| Blood Pressure | 3 | 2017 | 8523 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 1635 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2023 | 5201 | 0.030 |
Why?
|
| Anemia, Hemolytic | 1 | 2013 | 163 | 0.030 |
Why?
|
| Streptococcus intermedius | 1 | 2011 | 3 | 0.030 |
Why?
|
| Life Tables | 2 | 2004 | 365 | 0.030 |
Why?
|
| Trace Elements | 1 | 2014 | 196 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2015 | 4044 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2003 | 1367 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 14656 | 0.020 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1993 | 309 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 2016 | 841 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2014 | 36247 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2003 | 2711 | 0.020 |
Why?
|
| Postoperative Period | 2 | 2012 | 1821 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 1633 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 6830 | 0.020 |
Why?
|
| Coronary Sinus | 1 | 2011 | 84 | 0.020 |
Why?
|
| Bilirubin | 1 | 2013 | 438 | 0.020 |
Why?
|
| Sternotomy | 1 | 2012 | 127 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2018 | 1342 | 0.020 |
Why?
|
| Trial of Labor | 1 | 2011 | 81 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2012 | 474 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 10829 | 0.020 |
Why?
|
| Aging | 1 | 2009 | 8641 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2022 | 2321 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 1628 | 0.020 |
Why?
|
| Delayed Diagnosis | 1 | 2014 | 463 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2013 | 9712 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2019 | 1705 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 2852 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2003 | 3728 | 0.020 |
Why?
|
| Critical Illness | 1 | 2003 | 2709 | 0.020 |
Why?
|
| Mortality | 1 | 2021 | 2916 | 0.020 |
Why?
|
| Decision Making | 1 | 2004 | 3924 | 0.020 |
Why?
|
| Equipment Failure | 2 | 2004 | 577 | 0.020 |
Why?
|
| Insurance Carriers | 1 | 2011 | 156 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2014 | 880 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2019 | 2633 | 0.020 |
Why?
|
| Recurrence | 4 | 2009 | 8487 | 0.020 |
Why?
|
| Quality of Life | 2 | 2024 | 13300 | 0.020 |
Why?
|
| Analgesia, Obstetrical | 1 | 2011 | 169 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2019 | 20484 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2001 | 1927 | 0.020 |
Why?
|
| Contrast Media | 1 | 2002 | 5301 | 0.020 |
Why?
|
| Anesthesia, Epidural | 1 | 2011 | 232 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 3 | 2013 | 7400 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2014 | 1181 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2010 | 614 | 0.020 |
Why?
|
| Atrial Flutter | 1 | 2010 | 258 | 0.020 |
Why?
|
| Vital Capacity | 1 | 2011 | 965 | 0.020 |
Why?
|
| Hospital Mortality | 2 | 2013 | 5420 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 1295 | 0.020 |
Why?
|
| Logistic Models | 2 | 2013 | 13311 | 0.020 |
Why?
|
| Labor, Obstetric | 1 | 2011 | 321 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2010 | 597 | 0.020 |
Why?
|
| Bupivacaine | 1 | 2011 | 413 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2001 | 2755 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 1945 | 0.020 |
Why?
|
| Blood Coagulation Disorders | 1 | 2010 | 349 | 0.020 |
Why?
|
| Sample Size | 1 | 2010 | 840 | 0.020 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2007 | 82 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2011 | 593 | 0.020 |
Why?
|
| Heart | 1 | 2020 | 4392 | 0.020 |
Why?
|
| Shock, Cardiogenic | 1 | 2013 | 734 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 14482 | 0.020 |
Why?
|
| Ticlopidine | 1 | 2012 | 895 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2012 | 976 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2019 | 5120 | 0.020 |
Why?
|
| Radiography | 2 | 2013 | 6965 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2011 | 1810 | 0.020 |
Why?
|
| Lung Transplantation | 1 | 1995 | 1304 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2016 | 2958 | 0.020 |
Why?
|
| Research Design | 2 | 2012 | 6181 | 0.020 |
Why?
|
| Health Services Research | 1 | 2013 | 1811 | 0.020 |
Why?
|
| Iron | 1 | 2014 | 1786 | 0.020 |
Why?
|
| Atherectomy | 1 | 2005 | 40 | 0.020 |
Why?
|
| Leg | 1 | 2010 | 1091 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 749 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2011 | 1422 | 0.020 |
Why?
|
| Chest Pain | 1 | 2012 | 1106 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2012 | 1266 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3466 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2011 | 941 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2015 | 2877 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 2004 | 375 | 0.010 |
Why?
|
| Safety Management | 1 | 2010 | 760 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 2011 | 1001 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2007 | 23363 | 0.010 |
Why?
|
| Cementation | 1 | 2003 | 92 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 11064 | 0.010 |
Why?
|
| International Classification of Diseases | 1 | 2008 | 884 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2013 | 2283 | 0.010 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2006 | 865 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2007 | 1096 | 0.010 |
Why?
|
| Anthropometry | 1 | 2006 | 1348 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8805 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 2003 | 298 | 0.010 |
Why?
|
| Education, Medical | 1 | 2013 | 1728 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 6499 | 0.010 |
Why?
|
| Beta Particles | 1 | 2001 | 47 | 0.010 |
Why?
|
| Acute Disease | 1 | 2012 | 7268 | 0.010 |
Why?
|
| Device Removal | 1 | 2006 | 634 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 3526 | 0.010 |
Why?
|
| Venous Thrombosis | 1 | 2010 | 1293 | 0.010 |
Why?
|
| Risk | 1 | 2013 | 9629 | 0.010 |
Why?
|
| Models, Biological | 1 | 2016 | 9468 | 0.010 |
Why?
|
| Heart Rate | 1 | 2011 | 4169 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2006 | 1186 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16543 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13967 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2005 | 2646 | 0.010 |
Why?
|
| Aortography | 1 | 2000 | 419 | 0.010 |
Why?
|
| Scleroderma, Systemic | 1 | 2002 | 344 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2001 | 694 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2003 | 2295 | 0.010 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2001 | 560 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 2476 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 2893 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 2001 | 943 | 0.010 |
Why?
|
| Angiography | 1 | 2002 | 1605 | 0.010 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2001 | 784 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2001 | 1684 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2012 | 3840 | 0.010 |
Why?
|
| omega-N-Methylarginine | 1 | 1996 | 108 | 0.010 |
Why?
|
| Cineangiography | 1 | 1995 | 113 | 0.010 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 1996 | 107 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1998 | 1375 | 0.010 |
Why?
|
| Walking | 1 | 2002 | 1190 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 4189 | 0.010 |
Why?
|
| Atrial Function, Left | 1 | 1995 | 186 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1995 | 378 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2001 | 1503 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2006 | 5513 | 0.010 |
Why?
|
| Lung | 1 | 2011 | 9989 | 0.010 |
Why?
|
| Arginine | 1 | 1996 | 934 | 0.010 |
Why?
|
| Animals | 2 | 2014 | 167940 | 0.010 |
Why?
|
| Depression | 1 | 2011 | 8033 | 0.010 |
Why?
|
| Vasodilation | 1 | 1996 | 964 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1993 | 642 | 0.010 |
Why?
|
| Atrial Fibrillation | 1 | 2010 | 5201 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2005 | 5993 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2002 | 2160 | 0.010 |
Why?
|
| Age of Onset | 1 | 1996 | 3302 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2002 | 4044 | 0.010 |
Why?
|
| Fatigue | 1 | 1996 | 1544 | 0.000 |
Why?
|
| Calcinosis | 1 | 1994 | 1478 | 0.000 |
Why?
|